DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...

Don't want to spend a fortune and break the bank on investing in growth stocks? If you're looking for cheap growth stocks to ...

Many Americans have flocked to cheaper, compounded versions of GLP-1 weight loss drugs in lieu of brand-name treatments. That competition is cutting into demand for Novo Nordisk’s prescriptions, a ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug ...

The Stargate announcement has also driven bullish sentiment as the AI data center expansion will drive significant energy ...

The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

Global Partners LP (NYSE:GLP) Q1 2024 Earnings Call Transcript May 8, 2024 Global Partners LP misses on earnings expectations. Reported EPS is $-0.37258 EPS, expectations were $0.1. GLP isn’t ...

The Air Force 1 '07 stands as the most authentic version of its predecessor while presenting a straightforward design using leather construction and a perforated toe box together with its signature ...

For years, obesity was often seen as a result of poor lifestyle choices. However, experts now suggest that biological factors ...

Juicy Marbles, known for its plant-based whole cuts, has released its cheapest meat analogue yet: a high-protein, high-fibre ...